Rumored Buzz on Healthcare News
Novo CEO pressed by Senate to cut price ranges of being overweight, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the company would think about new talks with insurers about the record costs of Wegovy and copyright if they pledge to help keep the medicines on their own formularies.CVS Well being may well c